MIAMI, Dec. 10, 2025 — Origis Energy, one of America’s leading renewable energy platforms, today announced financial close for the Swift Air Solar II and Swift Air Solar III projects in Ector County, Texas. The two projects have a combined nameplate capacity of 313 MWdc. The $290 million senior secured debt facilities include construction debt, term debt and a tax credit bridge loan from Natixis Corporate & Investment Banking (Natixis CIB) and Santander Corporate & Investment Banking (Santander).

Natixis CIB and Santander acted as coordinating lead arrangers and bookrunners, hedging banks, and LC issuers, with Natixis CIB serving as green loan coordinator and administrative agent for the $290 million debt financing package.

Swift Air Solar II and III will start commercial production in the fourth quarter of 2025. The projects will sell energy and renewable energy credits with Houston-based Occidental Power (Oxy) and its subsidiary, OLCV Stratos Development for Swift Air Solar II under two 15-year Power Purchase Agreements, to provide zero-emission solar power for the Direct Air Capture (DAC) facility, STRATOS, currently under construction in the Permian Basin. Earlier this year, Origis started commercial operation of the 184 MWdc Swift Air Solar I project, which is also contracted with Oxy.

Origis is the builder, owner, and operator of Swift Air Solar II and III. The two projects are the first phase of a larger, 600 MW complex in Ector County, in West Texas, with three additional projects expected to provide Full Notice to Proceed before the end of the year.

“We’re excited to have achieved this successful financing milestone for the Swift Air Solar projects. These projects further demonstrate Origis Energy’s ability to scale efficiently and mark another step toward bringing over 3 GW of long-term contracted assets into commercial operation by the end of 2026,” said Alice Heathcote, Chief Financial Officer, Origis Energy. “A big thank you to Natixis CIB and Santander for their ongoing partnership on both these transactions and beyond.”

The Swift Air Solar II and III financing represents the first project financing jointly led for Origis by Natixis CIB and Santander. The parties had previously worked together on the Origis $750 million construction warehouse facility in August 2023 and an upsize of the Origis $750 million development facility in March 2023.

“Natixis CIB is pleased to have supported Origis in the financing of the Swift Air II and III projects, alongside Santander. Origis, along with Antin, is an important client to Natixis CIB, and we look forward to continuing our long, collaborative and successful relationship in future transactions,” said Nasir Khan, Head of Real Assets & Global Trade Americas, Natixis CIB.

“Santander is proud to support Origis in financing Swift Air II and III, together with Natixis. Our longstanding relationship with Origis and Antin reflects our shared commitment to accelerating the energy transition, and we are pleased to further their continued growth,” said Andrew Platt, Head of Energy Structured Finance & Advisory US, Santander Corporate & Investment Banking.

Latham & Watkins represented Origis Energy in the transaction, together with Reed Smith as local counsel, while Milbank represented the lenders with support from Husch Blackwell as local counsel.

About Origis Energy

Origis Energy is accelerating the transition to a carbon-free future by Reimagining Zero℠. As one of America’s leading renewable energy and decarbonization solution platforms, the company continues to expand and reimagine its contribution to the world’s net-zero goals. Origis Energy puts customers first to deploy a wide range of sustainable solutions for grid power generation, performance optimization, and long-term operation of solar and energy storage plants across the U.S. Learn more at www.origisenergy.com.

SOURCE Origis Energy

MONTREAL, Dec. 10, 2025 – INLAN, a Montreal-based technology company pioneering next-generation battery-less IoT tags and AI-ready data infrastructure, is proud to announce it has raised US$ 5 million in series A funding led by strategic investor Saas Fee Limited, with strong participation from California-based VC investor Shea Ventures, as well as contributions from Montreal-based TandemLaunch and several strategic individual investors.

This new investment will enable INLAN to transition its breakthrough hardware into large-scale deployment and to expand the software and data backbone required to support massive IoT adoption across industrial and supply chain markets.

“AI is poised to fundamentally transform supply chain management, but only if the underlying data is granular, real-time, multidimensional, and reliable,” said Ali Shajii, CEO and Co-Founder of INLAN. “That level of data simply doesn’t exist today at scale, because the sensing technologies needed to capture it are either too limited or too expensive. INLAN was built to change that. With this funding, we can bring truly scalable, AI-ready data to the supply chain world and unlock the next generation of intelligent operations.” 

“We’ve spent the past two years developing a new class of battery-less tag that combines the affordability of RFID with the performance of active IoT devices,” said Mohammad Hajikhani, Co-Founder and CPO. “This funding marks an important milestone for INLAN and gives us the momentum we need to scale our technology into real-world supply chain environments. We’re excited to take the next steps toward making item-level intelligence accessible at truly massive scale.”

INLAN is creating a world where every item in the supply chain can continuously report where it is, how it’s doing, and what it needs, without the cost or complexity of today’s sensor technologies. By removing the trade-off between affordability and performance, INLAN makes it possible for businesses to access real-time, item-level intelligence at a scale that was previously out of reach. This means clearer visibility across operations, more reliable data for automation, and the ability to respond to issues the moment they arise.

INLAN was incubated at TandemLaunch, a Montreal-based deep-tech start-up foundry and seed fund. Emilie Boutros, Managing Partner added, “The support from a group of strategic and highly experienced international investors reflects our growing confidence in INLAN’s technology and its potential to transform large-scale data collection in industrial IoT and supply chain management. We welcome the opportunity to continue supporting INLAN’s journey.”

INLAN was advised by Pantek Securities, LLC, and Fasken Martineau DuMoulin LLP on the transaction. 

About INLAN

INLAN is a Canadian deep-tech company enabling real-time, item-level data at massive scale for modern supply chains and industrial IoT. By combining breakthrough tag chip technology with AI-ready data infrastructure, INLAN makes continuous, reliable, and granular operational insights accessible to businesses everywhere.

SOURCE INLAN

NESS ZIONA, Israel, Dec. 10, 2025 — VisIC Technologies Ltd., a pioneer in Gallium Nitride (GaN) power semiconductors for electric mobility, today announced the successful second closing of its Round B funding, securing $26 million. The round was led by a global semiconductor leader, with HKMC joining as a strategic investor. This milestone reinforces VisIC’s position at the forefront of GaN innovation for EV traction inverters and strengthens its role in enabling next-generation electric mobility.

The lead investor’s focus on advancing critical semiconductor technologies complements VisIC’s proprietary D³GaN™ platform, designed to deliver unmatched efficiency, scalability, and reliability for automotive drivetrains. HKMC’s participation underscores its commitment to integrating GaN technology into mass-production EV platforms.

The global EV market is experiencing rapid growth, with automakers racing to improve driving range, reduce costs, and meet stricter sustainability targets. A critical bottleneck lies in the efficiency and scalability of power electronics, particularly traction inverters, which directly impact vehicle performance and energy consumption.

Problem Statement
Traditional silicon-based solutions struggle to deliver the efficiency and power density required for next-generation EV platforms, especially at higher voltages. While SiC (Silicon Carbide) devices offer improved performance, their high cost and complex manufacturing limit widespread adoption. VisIC’s GaN-based D³GaN™ technology addresses these limitations by enabling smaller, lighter, and more efficient inverters—unlocking new possibilities for both 400V and 800V architectures.

Use of Funds
The new capital will accelerate VisIC’s roadmap, including:

• Optimization, qualification, and release of Gen3 750V GaN dice and power modules.
• Development of Gen4 1350V GaN technology, supporting the full spectrum of EV designs.
• Stabilization of the supply chain and ramp-up of GaN product delivery for EV traction inverters.
• Expansion into emerging 800V data center power requirements, leveraging the same advanced GaN platform.

Executive Quotes
Tamara Baksht, CEO of VisIC Technologies:
“This investment marks a major milestone for VisIC and the global EV industry. Our D³GaN technology is redefining power electronics for electric vehicles, and the support of our strategic partners accelerates our mission to deliver high-efficiency, scalable solutions for the next generation of mobility.”

 Hyundai Motor Company and Kia:
“Hyundai Motor Company and Kia are committed to advancing sustainable mobility. Partnering with VisIC enables us to integrate cutting-edge GaN power technologies into our EV platforms, enhancing efficiency, reliability, and performance as we shape the future of electric transportation.”

Contact:

Dieter Liesabeths
[email protected]

Logo: https://mma.prnewswire.com/media/1134462/VisIC_Technologies_Logo.jpg

Mission-aligned investors back platform enabling personalized, cross-brand cooking experiences

DUBLIN, Dec. 10, 2025 — Fresco, the platform powering smart cooking experiences for the world’s leading appliance brands, today announced the closing of its Series C funding round of €15 million, backed by a group of investors committed to reshaping the future of food, home cooking, and connectivity. The round includes new investment from Samuel Dennigan (Strong Roots), Barry Napier (Cubic³), and Tyler Hu (Arda), alongside follow-on participation from existing investors Middleby, ACT Venture Capital, AE Ventures, Morpheus Ventures, and Alsop Louie Partners.

The global smart kitchen appliances market is projected to reach approximately USD 60 billion by 2030; however, most appliance brands still lack a way to deliver personalized cooking experiences at scale, a gap that Fresco solves.

The funding will accelerate the evolution of its AI Cooking Companion, a personalized, appliance-aware sous chef that suggests recipes, guides home cooks in real time, and intelligently controls and syncs appliances so meals turn out perfectly, whether through screens, voice, or seamlessly across both. The investment will enable Fresco to scale this experience globally through partnerships with the biggest appliance brands.

The round follows a wave of industry adoption, including new OEM partnerships with E.G.O. and Arda, who manufacture appliances and components for hundreds of global brands. By integrating at this layer, Fresco has the potential to be distributed across every appliance built by these OEMs, enabling onboarding in days rather than months and rapidly extending the reach of Fresco’s cross-brand platform, KitchenOS, and the AI Cooking Companion.

“Almost every part of daily life has been transformed by technology except the kitchen, where the opportunity to help people is arguably the biggest,” said Ben Harris, CEO and co-founder of Fresco. “Fresco already connects all the pieces, positioning us to make AI genuinely useful in the kitchen, personalizing every cooking experience to make it effortless to cook a delicious, healthy meal. And as more partners join the ecosystem, the experience gets better and smarter for everyone.”

Fresco already powers cooking experiences across appliances from global brands, including Panasonic, Instant Pot Brands, Viking, Kenwood, and more, enabling home cooks to enjoy intuitive, guided cooking that works with the devices they own. With this next phase of growth, Fresco is evolving from powering connected appliances to driving intelligent, personalized cooking at scale. 

“As someone who has spent years helping people make better everyday food choices, Fresco feels like the next step. Not just changing what we eat, but how we cook, using technology to make it easier, more personal and more sustainable,” said Samuel Dennigan, who scaled Strong Roots into one of Europe’s leading consumer food brands.

“Fresco is delivering the scale and simplicity this industry has been waiting for-making intelligence in the kitchen invisible, effortless, and deeply personal. It’s the only ecosystem capable of harmonizing hardware, connectivity, and AI to truly transform how we cook,” said Barry Napier, CEO of Cubic³, who led the company through its global automotive connectivity expansion and acquisition.

About Fresco

Fresco is the smart kitchen platform trusted by the world’s leading appliance brands to launch faster, deliver better customer experiences, and accelerate digital transformation. Powered by KitchenOS and the Fresco AI Cooking Companion, the platform connects any appliance across any brand and supports rapid onboarding, global scalability, and 15+ languages. Fresco works with partners including Panasonic, Middleby, Kenwood, Instant Pot Brands, Bosch, GE Appliances, LG, and more, and operates globally from offices in Dublin and Madrid. To learn more, visit frescocooks.com.

SOURCE Fresco

SHANGHAI, Dec. 9, 2025 — D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.

The funding round was backed by a distinguished group of investors, including IDG Capital and SongQing Capital. Existing investors — WuXi AppTec’s Corporate Venture Fund, Temasek, HSG, MPCi, and Medicxi — also contributed to the round. The robust involvement from both new and current investors highlights widespread confidence in D3 Bio’s innovative pipeline and its global development strategy.

Proceeds from this financing will primarily support the planned global Phase III pivotal program for the company’s lead asset, elisrasib (D3S-001). These pivotal trials will assess elisrasib as both a monotherapy and in combination therapies for KRAS G12C-mutant cancers across key countries and regions, including the United States, China, and the European Union, to facilitate global regulatory submissions.

Furthermore, the funding will facilitate ongoing development of D3 Bio’s comprehensive pipeline of targeted and immuno-oncology programs, which are centred on innovative mechanisms with first-in-class or best-in-class potential.

Dr. George Chen, Founder, Chairman, and CEO of D3 Bio, stated, “The completion of our Series B financing demonstrates the strong confidence our investors place in our vision, scientific approach, business operations, and global development capabilities. This funding enables us to advance our lead program into late-stage clinical trials and further expand our pipeline of innovative therapies designed to benefit patients globally.”

Dr. Antoine Yver, Member of the Board of Directors and Scientific Committee of D3 Bio, stated, “This financing demonstrates that the swift and effective pursuit of the best- or first-in-class science is meaningful to society, and validates D3 Bio’s leading innovation, scientific vision and development strategy. It also highlights the unique potential of elisrasib for individuals affected by KRAS G12C-mutant cancers.”

About D3 Bio
D3 Bio is a global biotechnology company focused on the discovery, development, and registration of new medicines in oncology and immunology. The company’s discovery and development platforms leverage proprietary clinical insight and biomarker strategies to create novel and clinically meaningful therapies for patients in need. D3 Bio’s oncology programs target driver mutations or critical immune pathways and are designed to have first-in-class or best-in-class potential. D3 Bio owns global rights for all of its programs.

For more information, please visit www.d3bio.com. 

SOURCE D3 Bio, Inc.

Grant to expand program in Atlanta and strengthen Indianapolis programming

ALEXANDRIA, Va. and INDIANAPOLIS, Dec. 9, 2025 — CHC: Creating Healthier Communities (CHC) today announced an additional $700,000 in funding from Elevance Health Foundation to expand the reach of its Better Births Initiative (BBI)—a nationally recognized program improving maternal health outcomes and reducing the high rates of preterm births in under-resourced communities.

Many women face a higher risk of preterm birth and complications during pregnancy. In fact, one out of every 2,000 Black women die during childbirth, a rate roughly 2.7 times higher than the national average. By partnering with community-based organizations, the BBI program improves access to reproductive health care, addresses social drivers of health, and strengthens support systems for expectant mothers.

Proven Impact on Maternal Health
Since launching in 2022, BBI has delivered measurable improvements in maternal health outcomes:

• Program participants carried pregnancies to full term at a rate of 91.2%, compared to 85.3% nationally for the program’s target population – an improvement of approximately six percentage points.
• The average delivery occurred at 38.5 weeks, with nearly all preterm births occurring in the moderate-to-late preterm range.
• Participants experienced a 70% reduction in anxiety symptoms from intake to program completion.
• The program has connected more than 360 mothers with trained doulas and comprehensive prenatal support.

“For nearly 70 years, CHC has partnered with thousands of organizations to improve health and well-being in communities across the country,” said Demetrius Geiger, Program Manager, CHC: Creating Healthier Communities. “We are grateful to Elevance Health Foundation for their continued commitment to this work and the leadership of our partners. We are strengthening a maternal health ecosystem that delivers meaningful, lasting results for families and sets a new standard for coordinated care.”

Expanding Community-Based Maternal Care in Atlanta
Building on this success, CHC will expand BBI services to reach up to 300 more pregnant women in Atlanta through an integrated doula and community health worker coordinated care model, providing both birth-related and social support services. CHC will also expand its core evaluation measures to include elective and emergent delivery outcomes, hospital readmissions, and neonatal intensive care unit (NICU) admissions, vital measures that reveal risks, highlight opportunities, and drive life-saving improvements in maternal care. Expanded eligibility requirements will ensure that more expectant mothers receive timely, comprehensive care.

Scaling Innovative Solutions in Indianapolis
In Indianapolis, CHC’s Community Leadership Action Board (CoLAB) has united cross-sector partners, doulas, and community voices to identify urgent gaps in maternal care. With renewed backing from the Elevance Health Foundation, this collaboration has produced actionable solutions, including strengthening referral systems, building workforce capacity, and now driving the next phase of maternal health innovation in the city.

Through the CoLAB, CHC is advancing a systems-level maternal health model. Partnerships will strengthen and align referral systems, embed social determinants of health into maternal supports, and expand the capacity of local community-based organizations. This collaborative approach ensures that 180 pregnant women receive seamless access to essential services spanning from housing, food, transportation, and behavioral health, and childcare, while creating a foundation for lasting improvements in maternal outcomes, helping ensure women and their babies achieve optimal health and well-being.

“Elevance Health Foundation is committed to addressing the root causes of maternal health disparities,” said Shantanu Agrawal, MD, Chief Health Officer of Elevance Health. “Our continued partnership with CHC reflects our belief in community-led innovation, solutions that elevate doulas, strengthen referral networks, and set a new benchmark for maternal health nationwide.”

Since 2015, the Elevance Foundation has invested in maternal health programs ranging from prenatal care to mental health support. By funding programs like CHC’s Better Births Initiative, Elevance Health Foundation drives meaningful, measurable change in communities, supporting innovative solutions and empowering organizations to tackle critical health challenges.

About CHC: Creating Healthier Communities
For nearly 70 years, CHC: Creating Healthier Communities has united nonprofits, businesses, and communities to drive scalable impact that improves lives and strengthens communities. With a network of 5,000+ partners nationwide, CHC addresses the barriers to health so every person, no matter their zip code, can live their healthiest life. Join us at chcimpact.org or follow us on social media @chcimpact

About Elevance Health Foundation
Elevance Health Foundation is the philanthropic arm of Elevance Health Inc. The Foundation works to improve the health of the socially vulnerable through partnerships and programs in our communities with an emphasis on maternal-infant health; behavioral health; and food as medicine. Through its key areas of focus, the Foundation also strategically aligns with Elevance Health’s focus on community health and becoming a lifetime, trusted health partner that is fueled by its purpose to improve the health of humanity. To learn more about Elevance Health Foundation, please visit or follow us @ElevanceFND on X and Elevance Health Foundation on Facebook.

SOURCE Creating Healthier Communities

NEW YORK, Dec. 9, 2025 — Radial today announced the company has raised $50 million in venture funding to create access to the world’s most advanced mental health treatments. The company is backed by General Catalyst, who led the Series A, and additional investors Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, and Diede van Lamoen.

New brain medicines – treatments like neuromodulation (e.g. accelerated transcranial magnetic stimulation, (TMS)) and rapid-acting medications (e.g. Spravato) that directly heal the brain – are achieving far better outcomes for patients with mental health conditions. These treatments work in days to weeks, with some studies showing remission rates as high as 78%. However, the current healthcare system is designed to deliver long-term medication-based management, not the more episodic interventional brain medicine supported by modern evidence. Further, the system does not measure outcomes, which limits payors ability to pay for the best care possible, and clinicians lack the best clinical decision support and operational tools to enable these new forms of care at scale.

Radial is addressing this problem for patients, providers, and payers by developing clinical infrastructure, reimbursement tools, and decision support that’s designed around modern brain medicine. The company is building a national network of clinics that accept most major forms of insurance, including Medicare, Tricare, VA-CCN, Aetna, Cigna, United, and many Blues plans. For patients, this means the most effective combination of therapies are available to everyone who needs them. For clinicians, this means focusing on providing that care. And, for payors, this means better outcomes and less ultimate cost for even the most complex patients.

John Capecelatro, CEO and co-founder of Radial, commented, “People who are struggling with mental health can’t wait years to see if something might help through trial and error. New rapid-acting treatments work in days or weeks instead of years. We’re seeing remission rates for depression of 50-60% and as high as 78% in some studies our team has co-authored. The healthcare system hasn’t caught up. Radial is here to change that. When we have tools for the right clinical workflows and insurance pathways, people can access therapies that help them get better far sooner. It’s a dramatic difference for individuals, for families, and for the health system that ends up carrying the cost when care drags on without results.”

Reva Nohria, Partner at General Catalyst, said, “Psychiatry is undergoing a transformation, but most of that progress hasn’t reached patients. The science is there, yet the infrastructure to deliver modern, brain-based treatments at scale is still missing. Radial understands both the clinical evidence and the operational complexity required to close that gap. We believe this work can meaningfully expand access to effective mental health care.”

Owen Muir, Chief Medical Officer at Radial, added, “In research, we’ve proven that these powerful treatments work. They change lives. The hard part has always been bringing them into everyday clinical practice. Radial was built to close that gap. We’re taking what we know from years of clinical research and turning it into care that any patient can access. Radial is focused on the care patients have long deserved.”

Radial currently operates with seven clinics in six states, supported by its proprietary software platform. This fundraising will support the company’s plans to expand nationally in 2026, growing both its clinic network and technology partnerships.

About Radial
Radial is expanding access to the world’s most advanced mental health treatments by Radial is developing clinical infrastructure, reimbursement tools, and AI-guided decision support designed around novel psychiatry treatments like neuromodulation (e.g. TMS), medication (e.g. Spravato), and other interventional therapies. Their goal is to make transformative brain medicine accessible to all. Learn more at www.meetradial.com.

Media Contact:
Jacquelyn Miller
‪415-745-1794
[email protected]

SOURCE Radial

PHOENIX, Dec. 9, 2025 — Cloverleaf Networks, a leading provider of next-generation connectivity, cybersecurity, and collaboration solutions for modern workforces, today announced a strategic venture capital investment from Super K Ventures, a prominent early-stage technology investor known for backing high-growth companies transforming the digital infrastructure landscape.

This investment marks a significant milestone in Cloverleaf Networks’ mission to deliver a more resilient, intelligent, and customer-centric approach to business connectivity. The new funding will accelerate product innovation across the company’s flagship offerings—including Cloverleaf Connect, Cloverleaf Anywhere, Cloverleaf SASE, and collaboration platform Ryver—while expanding market reach in the United States and abroad.

“Super K Ventures’ investment is a strong validation of our vision to modernize business connectivity and cybersecurity through simplicity, transparency, and an unmatched customer experience,” said Joe Faherty, Founder & CEO of Cloverleaf Networks. “This partnership positions us to scale faster, innovate deeper, and deliver even greater value to the organizations that rely on Cloverleaf every day.”

Super K Ventures brings deep expertise in scaling B2B infrastructure, SaaS, and cloud-native technology firms. Their support will help Cloverleaf Networks accelerate hiring in engineering, product development, and customer success, while also expanding its national footprint of managed service capabilities.

“Cloverleaf Networks is redefining how companies connect, protect, and manage their distributed workforce environments,” said Renee Klenert, Managing Partner at Super K Ventures. “The combination of their technology, customer-centric culture, and operational excellence represents exactly what we look for in a long-term partner.”

Cloverleaf Networks’ SaaS platform CLOE remains a core differentiator, providing centralized visibility, proactive monitoring, and simplified network management from a single intuitive interface. CLOE will expand its AI-driven analytics and automation capabilities, empowering IT teams to maintain network health and security in real time.

About Cloverleaf Networks

Cloverleaf Networks provides fully managed, secure, cloud-optimized connectivity solutions for remote, hybrid, and multi-site businesses. Headquartered in Phoenix, Arizona, Cloverleaf delivers internet, SD-WAN, cybersecurity, and collaboration services powered by its CLOE operations platform and backed by the Emerald Service Commitment.

About Super K Ventures

Super K Ventures is a venture capital firm focused on early-stage investments in high-growth technology companies. With an emphasis on digital infrastructure, enterprise software, and AI-driven platforms, Super K Ventures partners with visionary founders to accelerate innovation and scale transformative businesses.

SOURCE Cloverleaf Networks

Opine’s new funding, led by S3 Ventures, solves a decades-old problem for companies selling complex solutions, where selling and delivering their solutions requires detailed multi-department synchronization.

RALEIGH, N.C., Dec. 9, 2025 — Opine announced today that it has raised five million USD in new financing led by S3 Ventures of Austin, Texas, with participation from Knoll Ventures, Atlanta Seed Company, Gray Ventures, Propel Ventures, Triangle Tweener Fund, and Feross Aboukhadijeh, CEO of Socket.dev. This investment comes after Opine recorded 10x revenue growth in 2025, establishing itself as a rapidly growing market necessity. The capital will accelerate development of Opine’s unified AI-native workspace designed to streamline the entire technical sales cycle from initial discovery to post-sale delivery for complex B2B technology vendors.

Complex enterprise deals often span multiple departments, rely on an array of unconnected tools, and are hampered by siloed conversations. Solution engineers spend hours rebuilding context, leaders lack visibility into deal risks, and post-sales teams often inherit customers without knowing what was promised. Opine was created to fix this by bringing every team, data source, and process into a single intelligent workspace that surfaces risks early, automates repetitive work, captures every evaluation and handoff accurately, and keeps everyone aligned throughout the customer lifecycle.

“We’re excited to use this funding to continue to grow and support our innovative customers. They’re building and selling some of the most sophisticated B2B solutions available and need a unified AI-native system that understands their market and supports all the effort that goes into winning complex deals. This investment allows us to deepen our AI capabilities, advance our product, and expand our go-to-market reach,” said Akash Ganapathi, CEO and co-founder of Opine.

“We are thrilled to be backing the Opine team. After we spoke to executives at multiple customers, it became clear that Opine’s AI-native platform consistently makes sales, customer success, and product teams more effective at winning new business and delivering value,” said Eric Engineer, Partner at S3 Ventures.

“Since switching to Opine earlier this year, we’ve gained clearer opportunity insights, faster answers, and tighter team alignment, often cutting out a 30-minute call with a single question. We’re excited to expand our use of their playbooks and to see what the team builds next with their new funding,” said Mark Rida, Director of Solutions Engineering (Opine customer).

“The Opine team really understands the challenges of presales teams at scale. You can feel it in how they’ve built their product and with every interaction with their team. We’re happy to be able to deliver an excellent working experience to our prospects and customers,” shared Jaime Lewis-Gross, SVP, Sales Engineering (Opine customer).

Opine plans to use the capital to advance workflow automation, real-time deal intelligence, and unified data infrastructure. The company will also expand its market presence as technical sales becomes one of the most strategic functions in modern B2B organizations.

About Opine

Opine is an AI-native workspace built for technical sales teams, connecting presales to post-sales in one intelligent system. By automating workflows, surfacing real-time insights, and bringing every stakeholder together, Opine helps revenue-critical teams move faster, sell smarter, and deliver lossless customer handoffs. The platform replaces spreadsheets, tribal knowledge, and manual updates with a unified solution that reflects how technical sales actually operates. Founded in Raleigh, Opine is trusted by leading B2B companies to close complex deals with clarity and precision across an ever-increasingly complex and fast-moving world. Learn more about Opine at www.tryopine.com 

About S3 Ventures

Founded in 2005, S3 Ventures is one of the largest and longest-serving venture capital firms based in Texas, but investing nationwide. Backed by a philanthropic family with a multi-billion-dollar foundation, we empower visionary founders with the patient capital and true resources required to grow extraordinary, high-impact companies in Business Software and Healthcare Technology. With over $1B in assets under management, we lead Seed, Series A, and Series B rounds, with initial investments ranging from $500K to $15M and the capacity to invest $25M over the life of a company. Learn more at www.s3vc.com.

CONTACT: Nate Meadows; Head of Marketing, Opine; [email protected]

SOURCE Opine